ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998